Drug discovery through the isolation of natural products from Burkholderia.

Adam Foxfire, Andrew Riley Buhrow, Ravi S Orugunty, Leif Smith

Expert opinion on drug discovery 2021 Jul

filter terms:

Introduction: The increasing threat of antibiotic-resistant pathogens makes it imperative that new antibiotics to combat them are discovered. Burkholderia is a genus of Gram-negative, non-sporulating bacteria. While ubiquitous and capable of growing within plants and groundwater, they are primarily soil-dwelling organisms. These include the more virulent forms of Burkholderia such as Burkholderia mallei, Burkholderia pseudomallei, and the Burkholderia cepacia complex (Bcc).Areas covered: This review provides a synopsis of current research on the natural products isolated from the genus Burkholderia. The authors also cover the research on the drug discovery efforts that have been performed on the natural products derived from Burkholderia.Expert opinion: Though Burkholderia has a small number of pathogenic species, the majority of the genus is avirulent and almost all members of the genus are capable of producing useful antimicrobial products that could potentially lead to the development of novel therapeutics against infectious diseases. The need for discovery of new antibiotics is urgent due to the ever-increasing prevalence of antibiotic-resistant pathogens, coupled with the decline in the discovery of new antibiotics.

Citation

Adam Foxfire, Andrew Riley Buhrow, Ravi S Orugunty, Leif Smith. Drug discovery through the isolation of natural products from Burkholderia. Expert opinion on drug discovery. 2021 Jul;16(7):807-822